Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Foxwell AR, Kyd JM, Cripps AW.

Microbiol Mol Biol Rev. 1998 Jun;62(2):294-308.

2.

Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.

Hong W, Peng D, Rivera M, Gu XX.

Microbes Infect. 2010 Jan;12(1):11-8. doi: 10.1016/j.micinf.2009.09.006. Epub 2009 Sep 24.

4.
6.

Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen.

Duell BL, Su YC, Riesbeck K.

FEBS Lett. 2016 Nov;590(21):3840-3853. doi: 10.1002/1873-3468.12351. Epub 2016 Aug 25. Review.

7.

Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.

Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, Lobet Y.

Vaccine. 2000 Dec 8;19 Suppl 1:S108-15. Review.

PMID:
11163473
8.

Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media.

Langereis JD, Stol K, Schweda EK, Twelkmeyer B, Bootsma HJ, de Vries SP, Burghout P, Diavatopoulos DA, Hermans PW.

MBio. 2012 Jul 3;3(4):e00079-12. doi: 10.1128/mBio.00079-12. Print 2012.

11.

[Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae].

Tian GZ, Zhang L, Shao ZJ.

Zhongguo Yi Miao He Mian Yi. 2009 Apr;15(2):174-9. Chinese.

PMID:
20077666
12.

Why we need a vaccine for non-typeable Haemophilus influenzae.

Cerquetti M, Giufrè M.

Hum Vaccin Immunother. 2016 Sep;12(9):2357-61. doi: 10.1080/21645515.2016.1174354. Epub 2016 May 12.

14.
15.
16.

Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model.

Green BA, Vazquez ME, Zlotnick GW, Quigley-Reape G, Swarts JD, Green I, Cowell JL, Bluestone CD, Doyle WJ.

Infect Immun. 1993 May;61(5):1950-7.

17.

Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.

Khan MN, Ren D, Kaur R, Basha S, Zagursky R, Pichichero ME.

Expert Rev Vaccines. 2016 Jul;15(7):863-78. doi: 10.1586/14760584.2016.1156539. Epub 2016 Mar 17. Review.

PMID:
26894630
18.
20.

Virulence phenotypes of low-passage clinical isolates of nontypeable Haemophilus influenzae assessed using the chinchilla laniger model of otitis media.

Buchinsky FJ, Forbes ML, Hayes JD, Shen K, Ezzo S, Compliment J, Hogg J, Hiller NL, Hu FZ, Post JC, Ehrlich GD.

BMC Microbiol. 2007 Jun 14;7:56.

Supplemental Content

Support Center